Novo Nordisk North America Operations A/S
CVR 33761201 · Public limited company (A/S) · Active · Low risk
Novo Nordisk North America Operations A/S is a Public limited company (A/S), founded on , based in Bagsværd. The company is registered in the industry anden finansiel formidling i.a.n.. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 15 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 60.0m and a net result of DKK -74.1m. CEO: Anders Rytter Mikkelsen.
Bankruptcy risk for Novo Nordisk North America Operations A/S
0.0 × the average (1.41%) · higher risk than 27% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 33761201
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (15 years)
- Address
- c/o Novo Nordisk A/S, Novo Alle 1
2880 Bagsværd - Municipality
- Gladsaxe
- Industry
- Anden finansiel formidling i.a.n. (649990)
Bankruptcies in the industry: Ikke-finansielle holdingselskaber - Share capital
- DKK 1.0m
- Auditor
- DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 15 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 5.2% |
| Current ratio | 4% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 6 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 13 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -59k | DKK -119k | DKK -365k |
| Net profit | DKK -74.1m | DKK -89.2m | DKK 1.1bn |
| Equity | DKK 60.0m | DKK 438.3m | DKK 1.1bn |
| Total assets | DKK 1.2bn | DKK 1.3bn | DKK 1.8bn |
| Cash | DKK 47k | DKK 528k | – |
| Short-term debt | DKK 238.9m | DKK 202.0m | – |
| Tax owed | DKK 46.3m | DKK 12.1m | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class B · auditor's statement: Auditor's report on audited financial statements · DeloitteStatsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 159 | ||
| 1 Jan 2024 – 31 Dec 2024 | 154 | ||
| 1 Jan 2023 – 31 Dec 2023 | 156 | ||
| 1 Jan 2022 – 31 Dec 2022 | 145 | ||
| 1 Jan 2021 – 31 Dec 2021 | 140 | ||
| 1 Jan 2020 – 31 Dec 2020 | 147 | ||
| 1 Jan 2019 – 31 Dec 2019 | 150 | ||
| 1 Jan 2018 – 31 Dec 2018 | 147 | ||
| 1 Jan 2017 – 31 Dec 2017 | 135 | ||
| 1 Jan 2016 – 31 Dec 2016 | 129 | ||
| 1 Jan 2015 – 31 Dec 2015 | 131 | ||
| 1 Jan 2014 – 31 Dec 2014 | 117 | ||
| 1 Jan 2013 – 31 Dec 2013 | 132 | ||
| 1 Jan 2012 – 31 Dec 2012 | 129 | ||
| 14 Jun 2011 – 31 Dec 2011 | 134 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Anders Rytter Mikkelsen | Current | |
| CEO | Lars Green | ||
| CEO | Karsten Munk Knudsen | ||
| CEO | Peter Bøggild | ||
| Board | Linette Tangsgaard Nielsen | Current | |
| Board | Naja Eilers Barrisøe | Current | |
| Board | Thomas Rask Nielsen | Current | |
| Board | Kåre Schultz | ||
| Board | Ole Falvig Ramsby | ||
| Board | Jesper Brandgaard | ||
| Board | Lars Fruergaard Jørgensen | ||
| Board | Lene Moth Bang | ||
| Board | Karsten Munk Knudsen | ||
| Board | Tomas Haagen | ||
| Board | Kristine Aachmann Bethe | ||
| Board | John Francis Kuckelman | ||
| Owner (100%) | NOVO NORDISK A/S | Current | |
| Auditor | DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB | Current | |
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | NOVO NORDISK A/S | Current |
The CEOs' other companies
Anders Rytter Mikkelsen – 9 other companies
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- Novo Nordisk Denmark A/S Active
- Novo Nordisk Invest 4 A/S Active
Lars Green – 25 other companies
- Cerebriu A/S Active
- Green Housing ApS Active
- H. LUNDBECK A/S Active
- LEO Holding A/S Active
- LEO PHARMA A/S Active
- NOVO NORDISK A/S Active
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 1 A/S Opløst
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMA OPERATIONS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- NOVO NORDISK SECURITY A/S Opløst
- NOVOZYMES A/S Active
- NOVOZYMES BIOINDUSTRIAL A/S Active
- NOVOZYMES BIOINDUSTRIAL CHINA A/S Active
- Nordic Storm Holding A/S Active
- Novo Holdings A/S Active
- Novonesis Plant Biosolutions A/S Active
- Novozymes Biopharma DK A/S Opløst
- Novozymes Biotechnology ApS Fusioneret
- PHARMACOSMOS A/S Active
- Scandinavian Investment Group A/S Active
Karsten Munk Knudsen – 14 other companies
- 3SHAPE HOLDING A/S Active
- HEMPEL A/S Active
- NNE A/S Active
- NOVO NORDISK A/S Active
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMA OPERATIONS A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- Novo Nordisk Denmark A/S Active
- Novo Nordisk Invest 4 A/S Active
Peter Bøggild – 12 other companies
- Anpartsselskabet af 21.08.2026 Opløst
- NNIT A/S Active
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- Novo Nordisk Invest 4 A/S Active
- PBGG Holding ApS Active
- TRIO INVEST ApS Opløst
Address history (0 moves)
| c/o Novo Nordisk A/S, Novo Alle 1, 2880 Bagsværd |
Former names
| Novo Nordisk North America Operations A/S | – now |
| Novo Nordisk Invest 3 A/S | – |
| NOVO NORDISK REGION NORTH AMERICA II A/S | – |
Other companies at the same address
- NOVO NORDISK A/S Active
- NOVO NORDISK FARMAKA DANMARK A/S Opløst
- NOVO NORDISK GSC HOLDING A/S Active
- NOVO NORDISK INVEST 1 A/S Opløst
- NOVO NORDISK INVEST 2 A/S Active
- NOVO NORDISK PHARMA OPERATIONS A/S Active
- NOVO NORDISK PHARMACEUTICALS A/S Active
- NOVO NORDISK REGION AAMEO AND LATAM A/S Active
- NOVO NORDISK REGION CHINA A/S Active
- NOVO NORDISK REGION EUROPE A/S Active
- NOVO NORDISK REGION JAPAN & KOREA A/S Active
- NOVO NORDISK SECURITY A/S Opløst
- Novo Nordisk Invest 4 A/S Active
Similar companies in Gladsaxe
- Selskabet af 24. marts 1982 A/S Søborg
- BYENS BOLIG ApS Søborg
- CELA INVEST ApS Bagsværd
- O.P.Poulsen ApS Søborg
- HMØ HOLDING ApS Søborg
- Northwave Capital ApS Søborg
- Schneekloth Invest ApS Søborg
- Okkels Invest ApS Søborg
- Soft Deis Invest ApS Søborg
- Rasimi ApS Søborg
- PTCL Holding ApS Søborg
- OU Invest ApS Søborg
Questions and answers about Novo Nordisk North America Operations A/S
Has Novo Nordisk North America Operations A/S gone bankrupt?
No, Novo Nordisk North America Operations A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Novo Nordisk North America Operations A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of Novo Nordisk North America Operations A/S?
Anders Rytter Mikkelsen is the CEO of Novo Nordisk North America Operations A/S.
Who is the auditor of Novo Nordisk North America Operations A/S?
Novo Nordisk North America Operations A/S most recently used DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB.
When was Novo Nordisk North America Operations A/S founded?
Novo Nordisk North America Operations A/S was founded on 14 June 2011.
What is the equity of Novo Nordisk North America Operations A/S?
Equity was DKK 60.0m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.